VP
Vertex Pharmaceuticals Inc
🇺🇸XNAS.VRTXUnited StatesHealthcare
$516.85USDdown -2.66 (-0.51%)OpenEnd of day3:21 PM
Price$516.85-2.66 (-0.51%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US92532F1003
- CUSIP
- 92532F100
Company
- Employees
- 6,400
- Headquarters
- Boston, United States
- Website
- https://www.vrtx.com
- CEO
- Dr. Reshma Kewalramani FASN, M.D.
Market
- Shares outstanding
- 253.5M
- Market cap
- $131B
Key dates
- Next earnings
- Nov 2, 2026
Highlights
- Market cap
- $131B
- EPS LTM
- $17.23
- P/E LTM
- 28.83
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $12.62B+10.56%up year on year
- Net income
- $4.41B+21.1%up year on year
- Gross margin
- 86.04%-0.08%down year on year
- Free cash flow
- $3.8B+8.47%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.